Finance

Lists
688163:SHA
Shanghai Serum Bio-Technology Co Ltd
CN¥31,21
-0,86%
(-0,27) 1D
16 Okt., 15:00:02 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688163...
Open
CN¥32,00
High
CN¥32,78
Low
CN¥30,65
Mkt. cap
3,38 mjd
Avg. vol.
1,32 m
Volume
1,01 m
Dividend
1,22%
Quarterly dividend
CN¥0,10
Ex-dividend date
15 Sep. 2026
P/E ratio
62,02
52-wk high
CN¥52,88
52-wk low
CN¥21,20
EPS
CN¥0,50
No. of employees
336
Open
CN¥32,00
High
CN¥32,78
Low
CN¥30,65
Mkt. cap
3,38 mjd
Avg. vol.
1,32 m
Volume
1,01 m
Dividend
1,22%
Quarterly dividend
CN¥0,10
Ex-dividend date
15 Sep. 2026
P/E ratio
62,02
52-wk high
CN¥52,88
52-wk low
CN¥21,20
EPS
CN¥0,50
No. of employees
336
News stories
From web sources and news partners
About Shanghai Serum Bio-Technology Co Ltd
CEO-
Employees336
Founded09 Nov. 1999
Headquarters-
Sector-
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
74,32 m
21,07 m
27,09 m
77,12 m
Cost of goods sold
14,42 m
7,22 m
7,41 m
17,38 m
Cost of revenue
14,42 m
7,22 m
7,41 m
17,38 m
Research and development expenses
4,40 m
6,63 m
4,80 m
5,88 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
21,33 m
23,05 m
15,61 m
14,75 m
Operating expense
24,90 m
28,24 m
21,31 m
23,45 m
Total operating expenses
39,32 m
35,46 m
28,72 m
40,84 m
Operating income
35,00 m
-14,40 m
-1,62 m
36,28 m
Other non operating income
87,75 k
-86,13 k
-181,42 k
162,20 k
EBT including unusual items
37,05 m
-10,61 m
420,45 k
39,54 m
EBT excluding unusual items
38,54 m
-11,64 m
525,28 k
37,84 m
Income tax expense
5,82 m
1,81 m
-146,73 k
4,45 m
Effective tax rate
15,70%
-17,08%
-34,90%
11,26%
Other operating expenses
642,85 k
344,72 k
228,77 k
1,38 m
Net income
31,23 m
-12,42 m
567,18 k
35,08 m
Net profit margin
42,03%
-58,97%
2,09%
45,49%
Earnings per share
-
-
-
-
Interest and investment income
3,62 m
2,97 m
2,37 m
1,81 m
Interest expense
-40,60 k
-55,02 k
-39,15 k
-51,27 k
Net interest expenses
3,58 m
2,91 m
2,33 m
1,76 m
Depreciation and amortization charges
-
-
-
-
EBITDA
39,84 m
-9,75 m
3,03 m
41,34 m
Gain or loss from assets sale
-
-80,37 k
-
-14,15 k
AI content may include mistakes. Learn more
Google-programme